到 2028 年中东和非洲品牌仿制药市场预测 – COVID-19 影响和区域分析 – 按治疗应用(肿瘤学、心血管疾病、糖尿病、神经病学、胃肠道疾病、皮肤病、镇痛药和抗炎药等) )、分销渠道(医院、零售药店、网上药店和药店)、药品类别(烷化剂、抗代谢药、激素、抗高血压药、降脂药、抗抑郁药、抗精神病药、抗癫痫药等)和剂型类型(口服药) 、肠外、局部用药等)

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2028


No. of Pages: 174    |    Report Code: BMIRE00026051    |    Category: Life Sciences

Middle East & Africa Branded Generics Market

中东和中东地区的品牌仿制药市场非洲预计将从 2022 年的 211.2 亿美元增长到 2028 年的 337.8 亿美元;预计 2022 年至 2028 年复合年增长率为 8.1%。

 

仿制药在提供具有成本效益的治疗。 NCBI的一份报告指出,仿制药在剂型、规格、给药途径、质量、安全性、性能特征和预期用途方面与专利产品相当。 redalyc.org 的一份报告指出,医生、药剂师和患者是确保仿制药成功的关键利益相关者。此外,药剂师在大多数情况下是患者的第一联系人,也是仿制药信息的重要来源。因此,医疗保健提供者和专业人士越来越多地使用品牌仿制药,促进了中东和中东地区的增长。非洲品牌仿制药市场。

 

通过引入新功能和技术,中东和非洲的供应商非洲品牌仿制药市场可以吸引新客户并扩大其在新兴市场的足迹。这一因素可能会在预测期内推动市场实现良好的复合年增长率。

 

中东和中东地区非洲品牌仿制药

2028年市场收入和预测(十亿美元)

< /strong>

 

 

 

中东和;非洲品牌仿制药市场细分

 

中东和非洲非洲品牌仿制药市场分为治疗应用、分销渠道、药物类别、配方类型和国家。中东和非洲的治疗应用领域非洲品牌仿制药市场细分为肿瘤、心血管疾病、糖尿病、神经病学、胃肠道疾病、皮肤病、镇痛和抗炎药。 2022 年,按治疗应用划分,其他细分市场占据最大市场份额。中东和中东地区非洲品牌仿制药市场,按分销渠道划分为医院药房、零售药店、网上药店和药店。到 2022 年,零售药店领域可能会占据最大的市场份额。非洲品牌仿制药市场按药物类别分为烷化剂、抗代谢药、激素、抗高血压、降脂药、抗抑郁药、抗精神病药、抗癫痫药等。到 2022 年,其他细分市场可能会占据最大的市场份额。非洲品牌仿制药市场根据剂型类型分为口服、肠胃外、外用等。 2022 年,按配方类型划分,口服细分市场占据最大市场份额。基于国家、中东和地区非洲品牌仿制药市场分为沙特阿拉伯、南非、阿联酋以及中东和非洲其他地区。非洲。中东和非洲其他地区在 2022 年占据了最大的市场份额。

 

Aspen Holdings、阿斯利康、Bausch Health (Valeant Pharmaceuticals)、Dr. Reddy\'s Laboratories Inc.、葛兰素史克公司、Hetero、Lupin、Mylan NV、Par Pharmaceuticals、Sandoz International Gmbh、赛诺菲和 Teva Pharmaceutical Industries Ltd. 是该地区品牌仿制药市场的领先公司。   



Middle East & Africa Branded Generics Strategic Insights

Strategic insights for Middle East & Africa Branded Generics involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/middle-east-and-africa-branded-generics-market-strategic-framework.webp
Get more information on this report

Middle East & Africa Branded Generics Report Scope

Report Attribute Details
Market size in 2022 US$ 21.12 Billion
Market Size by 2028 US$ 33.78 Billion
Global CAGR (2022 - 2028) 8.1%
Historical Data 2020-2021
Forecast period 2023-2028
Segments Covered By 治疗应用
  • 肿瘤科
  • 心血管疾病
  • 糖尿病
  • 神经科
  • 胃肠道疾病
  • 皮肤病
  • 镇痛消炎
By 分销渠道
  • 医院
  • 零售药店
  • 网上药店
  • 药店
By 药物类别
  • 烷化剂
  • 抗代谢药
  • 激素
  • 抗高血压药
  • 降脂药
  • 抗抑郁药
  • 抗精神病药
  • 抗癫痫药
By 剂型类型
  • 口服
  • 肠胃外
  • 外用
Regions and Countries Covered 中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
Market leaders and key company profiles
  • Aspen Holdings
  • AstraZeneca
  • Bausch Health (Valeant Pharmaceuticals)
  • Dr. Reddys Laboratories Inc.
  • GlaxoSmithKline plc
  • Hetero
  • Lupin
  • Mylan N.V.
  • Par Pharmaceuticals
  • Sandoz International Gmbh
  • Get more information on this report

    Middle East & Africa Branded Generics Regional Insights

    The regional scope of Middle East & Africa Branded Generics refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/middle-east-and-africa-branded-generics-market-geography.webp
    Get more information on this report

    The List of Companies - Middle East & Africa Branded Generics Market

    1. Aspen Holdings
    2. AstraZeneca
    3. Bausch Health (Valeant Pharmaceuticals)
    4. Dr. Reddy's Laboratories Inc.
    5. GlaxoSmithKline plc
    6. Hetero
    7. Lupin
    8. Mylan N.V.
    9. Par Pharmaceuticals
    10. Sandoz International Gmbh
    11. Sanofi
    12. Teva Pharmaceutical Industries Ltd.  
    Frequently Asked Questions
    How big is the Middle East & Africa Branded Generics Market?

    The Middle East & Africa Branded Generics Market is valued at US$ 21.12 Billion in 2022, it is projected to reach US$ 33.78 Billion by 2028.

    What is the CAGR for Middle East & Africa Branded Generics Market by (2022 - 2028)?

    As per our report Middle East & Africa Branded Generics Market, the market size is valued at US$ 21.12 Billion in 2022, projecting it to reach US$ 33.78 Billion by 2028. This translates to a CAGR of approximately 8.1% during the forecast period.

    What segments are covered in this report?

    The Middle East & Africa Branded Generics Market report typically cover these key segments-

  • 治疗应用 (肿瘤科, 心血管疾病, 糖尿病, 神经科, 胃肠道疾病, 皮肤病, 镇痛消炎)
  • 分销渠道 (医院, 零售药店, 网上药店, 药店)
  • 药物类别 (烷化剂, 抗代谢药, 激素, 抗高血压药, 降脂药, 抗抑郁药, 抗精神病药, 抗癫痫药)
  • What is the historic period, base year, and forecast period taken for Middle East & Africa Branded Generics Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Middle East & Africa Branded Generics Market report:

  • Historic Period : 2020-2021
  • Base Year : 2022
  • Forecast Period : 2023-2028
  • Who are the major players in Middle East & Africa Branded Generics Market?

    The Middle East & Africa Branded Generics Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Aspen Holdings
  • AstraZeneca
  • Bausch Health (Valeant Pharmaceuticals)
  • Dr. Reddys Laboratories Inc.
  • GlaxoSmithKline plc
  • Hetero
  • Lupin
  • Mylan N.V.
  • Par Pharmaceuticals
  • Sandoz International Gmbh
  • Sanofi
  • Teva Pharmaceutical Industries Ltd.
  • Who should buy this report?

    The Middle East & Africa Branded Generics Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Middle East & Africa Branded Generics Market value chain can benefit from the information contained in a comprehensive market report.